Centrica PLC
Centrica plc (the Company)
Directors/PDMR shareholding
Deferred and Matching Share Scheme (DMSS) - share acquisitions and conditional
allocations
On 13 October 2008, the trustee of the DMSS purchased a total of 468,291
Centrica ordinary shares of 6 14/81 pence each at 273.75p and made conditional
awards of matching shares to Executive Directors and PDMRs, as detailed below.
-0-
*T
Executive Directors(1) Total number of Total number of Total beneficial
shares acquired in conditional interest in shares
DMSS( 2) matching shares following the
held (3, 4) awards
--------------------------- --------------------- ------------------- -------------------
Phillip Bentley 47,120 94,240 747,222
--------------------------- --------------------- ------------------- -------------------
Sam Laidlaw 146,828 402,097 489,362
--------------------------- --------------------- ------------------- -------------------
Nick Luff 74,438 201,671 275,249
--------------------------- --------------------- ------------------- -------------------
PDMRs
--------------------------- --------------------- ------------------- -------------------
Grant Dawson 48,754 132,417 380,581
--------------------------- --------------------- ------------------- -------------------
Deryk King 35,204 70,408 255,102
--------------------------- --------------------- ------------------- -------------------
Catherine May 23,316 54,246 30,053
--------------------------- --------------------- ------------------- -------------------
Anne Minto 46,782 124,564 195,415
--------------------------- --------------------- ------------------- -------------------
Chris Weston 45,849 106,927 199,994
--------------------------- --------------------- ------------------- -------------------
*T
(1 )Operation of the scheme was delayed from April 2008 due to a market enforced
prolonged period during which the Board were prohibited from dealing in, and
making awards over, Centrica shares. In accordance with the rules of the scheme,
the performance period will run from April 2008 until April 2011.
(2) 20% of gross bonus (before the deduction of income tax and National
Insurance contributions) was automatically deferred and invested in Centrica
shares. Participants had the opportunity to make a further investment, funded
from net annual performance bonus, so that the maximum total investment (on a
gross basis) was 50% of the individual's maximum bonus entitlement for 2007.
(3) The calculation of the conditional matching shares was made on a gross
basis. Investment shares are grossed up for the calculation of the matching
shares so that the deferred and investment shares are matched on the same basis.
(4 )The number of matching shares that vest will be determined on a
straight-line basis over a three-year period. The maximum two for one match will
be achieved for cumulative economic profit growth of 25% or more with zero
matching for no growth.
Enquiries:
Centrica Media Relations: 0845 072 8001
Centrica Investor Relations: 01753 494900
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.